A phase I clinical trial of topical peptide p144 TGF-beta1 inhibitor in healthy volunteers

被引：0
|
作者：
Sabada, Belen [1 ]
Ruiz, Belen [2 ]
Ruiz, Juan
Insa, Raul [3 ]
机构：
[1] Univ Navarra Clin, Pamplona, Spain
[2] Hosp Univ Puerta de Hierro, Madrid, Spain
[3] ISDIN, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2009年 / 60卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB63 / AB63
页数：1
相关论文
共 50 条
  • [21] Immediate hematological toxicity of linezolid in healthy volunteers with different body weight: a phase I clinical trial
    Yun Cai
    Dong Chai
    Matthew E Falagas
    Evridiki K Vouloumanou
    Rui Wang
    Daihong Guo
    Nan Bai
    Beibei Liang
    Youning Liu
    The Journal of Antibiotics, 2012, 65 : 175 - 178
  • [22] Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?
    Fisher, Jill A.
    McManus, Lisa
    Kalbaugh, Julianne M.
    Walker, Rebecca L.
    CLINICAL TRIALS, 2021, 18 (04) : 477 - 487
  • [23] FIRST-TIME-IN-HUMAN PHASE 1 CLINICAL TRIAL IN HEALTHY VOLUNTEERS WITH SNF472, A NOVEL INHIBITOR OF VASCULAR CALCIFICATION
    Perello, Joan
    Salcedo, Carolina
    Joubert, Pieter H.
    Canals, Ana Z.
    Ferrer, Miguel D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [24] The Effects of Moxifloxacin and Gemifloxacin on the ECG Morphology in Healthy Volunteers: A Phase 1 Randomized Clinical Trial
    Ullah, Abid
    Ahmad, Shujaat
    Ali, Niaz
    Hussain, Haya
    Allahyani, Mamdouh
    Almehmadi, Mazen
    Alsaiari, Ahad Amer
    Abdulaziz, Osama
    Almarshad, Feras
    Bukhari, Syeda Hajira
    DIAGNOSTICS, 2023, 13 (07)
  • [25] PHASE I TRIAL OF PYRAGREL, A NOVEL THROMBOXANE SYNTHETASE INHIBITOR, TO EVALUATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS IN HEALTHY VOLUNTEERS.
    Zou, C.
    Huang, J.
    Pei, Q.
    Yang, G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S78 - S78
  • [26] A Phase I randomized trial to assess the effects of Src inhibitor AZD0530 on renal function in healthy volunteers
    Chetty, R.
    Dalton, N.
    Rimmer, M.
    Cockburn, N.
    Smith, I.
    Swaisland, A.
    Hargreaves, J.
    Stuart, M.
    EJC SUPPLEMENTS, 2008, 6 (12): : 123 - 123
  • [27] Using "Clinical Trial Diaries" to Track Patterns of Participation for Serial Healthy Volunteers in US Phase I Studies
    Edelblute, Heather B.
    Fisher, Jill A.
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2015, 10 (01) : 65 - 75
  • [28] SCREENING AND RECRUITMENT PROCEDURES OF HEALTHY VOLUNTEERS IN A PHASE I CLINICAL TRIAL UNIT: EXPERIENCE OF 38 BIOEQUIVALENCE STUDIES
    Duque, B.
    Borobia, A. M.
    Mosquera, B.
    Duran, Lopez J. L. .
    Ramirez, E.
    Lubomirov, R.
    Carcas, A. J.
    Guerra, P.
    Frias, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 117 - 117
  • [29] SCREENING AND RECRUITMENT PROCEDURES OF HEALTHY VOLUNTEERS IN A PHASE I CLINICAL TRIAL UNIT: EXPERIENCE IN 64 BIOEQUIVALENCE STUDIES
    Duque, B.
    Borobia, A. M.
    Lubomirov, R.
    Ramirez, E.
    Guerra, P.
    Medrano, N.
    Tong, H. Y.
    Carcas, A. J.
    Frias, J.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E129 - E129
  • [30] Randomized Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Topical Daprodustat in Healthy Volunteers and in Patients With Diabetic Foot Ulcers
    Olson, Eric
    Mahar, Kelly M.
    Morgan, Lisa
    Fillmore, Christina
    Holland, Claire
    Lavery, Lawrence
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (06): : 765 - 778
12345